Skip to content
Secondary Progressive MS treatment fast-tracked for FDA Approval
hackwriter posted:
Opexa has changed the name of its drug, Tovaxin, to Tcelna, as it relaunches Phase IIb trials in 2012 in SPMS patients. See details in the link below:

Currently there is only one FDA-approved treatment for SPMS. Novantrone, originally a cancer chemotherapy, is an infusion therapy performed once every three months for up to 24 months for the treatment of Secondary-Progressive MS.
Was this Helpful?
2 of 3 found this helpful

Featuring Experts

Neil S. Lava, MD, is the director of the multiple sclerosis clinic at Emory University in Atlanta. He has been treating multiple sclerosis patients si...More

Helpful Tips

Reliv does work
I thought Reliv was a hoax too. But it's not. You need to take it regularly and consistently and it proves miracles. My mom was diagnosed ... More
Was this Helpful?
1 of 1 found this helpful

Related News

There was an error with this newsfeed

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.